Lightnews — Scholar-powered news

Reposted by Zaven Sargsyan

Goodishintent @omnintensivist.bsky.social · 2h

Rude

4 1 26

Zaven Sargsyan @sargsyanz.bsky.social · 3h

Degradation of validity, elusiveness of truth everywhere

Zaven Sargsyan @sargsyanz.bsky.social · 4h

Are a lot of google reviews fake / AI-generated now?

There's a company with 2.8 starts on 108 reviews on yelp

And 4.9 stars on 5,400 reviews on google - which all read very similar, and seem to concentrate heavily in the last several months.

My experience with the company was much more yelpy

1 1

Zaven Sargsyan @sargsyanz.bsky.social · 6h

Second one has a flagellum

1

Zaven Sargsyan @sargsyanz.bsky.social · 14h

Thanks.. I think some of it is driven by HF care accreditation/quality metrics imposed from on high (ACC or AHA)?

1

Reposted by Zaven Sargsyan

James 🎃cello 🌉 @jamespirruccello.com · 1d

If non-dramas are allowed, Scrubs, to me, is the most evocative of what it was like to be a medical resident.

3 1 5

Zaven Sargsyan @sargsyanz.bsky.social · 1d

The benefit of GDMT for HFrEF seems much greater / more important than of "GDMT" for HFpEF.

While the downsides--side effects, cost, pill burden, etc--are agnostic of benefit.

And yet I'm seeing a trend of "GDMT for HF" being increasingly conflated across the EF spectrum. Anyone else?

2 2

Reposted by Zaven Sargsyan

NEJM.org @nejm.org · 1d

A 23-year-old man with autism spectrum disorder and chronic constipation presented to the emergency department with a 1-week history of abdominal pain on his left side, nausea, and vomiting. 1/2

#MedSky

1 1 4

Zaven Sargsyan @sargsyanz.bsky.social · 1d

Interesting that they excluded uncomplicated cases.

Yes the complexity and risks of OPAT are greater in 6 rather than 2 weeks.

But much of it is front-loaded, e.g. PICC insertion, vanc levels/dosing, catheter thrombosis. Whereas cost of dalba linear with # of doses.

1

Reposted by Zaven Sargsyan

Paul Sax @paulsaxmd.bsky.social · 1d

What the DOTS trial of Staph bacteremia tells us:
• Dalbavancin d1 and d8 vs daily IVs for WEEKS
• No left-sided IE/CNS/prosthetics
• Dalba not superior by DOOR endpoint, but similar clinical outcomes.
Big implications for inpt care. More here! #IDSky tinyurl.com/3hjzkt96

DOTS: Optimism Around a “Negative” Dalbavancin Trial

The DOTS randomized clinical trial of dalbavancin versus standard-of-care for Staph aureus bacteremia (SAB) just landed in JAMA, where it undoubtedly will be featured in numerous ID, hospitalist, and ...

tinyurl.com

2 6 18

Reposted by Zaven Sargsyan

David Juurlink @davidjuurlink.bsky.social · Apr 10

Let's talk about using carbapenem antibiotics in patients with valproic acid (VPA) poisoning

/1🧵

3 15 28

Zaven Sargsyan @sargsyanz.bsky.social · 2d

Any tips / anticipatory guidance about people on VPA at therapeutic doses who develop an ESBL infection?

1

Reposted by Zaven Sargsyan

David Juurlink @davidjuurlink.bsky.social · 2d

PSA: When a naturopath recommends chelation “to remove the metal from your body,” that is exactly what you should not do.

4 3 32

Zaven Sargsyan @sargsyanz.bsky.social · 2d

Polycythemia falsa

5

Reposted by Zaven Sargsyan

Emily Fridenmaker @emilyfri.bsky.social · 2d

Discussing this article for our QI didactic on Monday. So good.

journal.chestnet.org/action/showP...

2 2 4

Zaven Sargsyan @sargsyanz.bsky.social · 2d

Also I love the thirsty evacuated container as the image of “decreased ascites formation” 😄

2

Zaven Sargsyan @sargsyanz.bsky.social · 2d

Great read, thanks yall.

I’ve always been struck by how some folks have a lot of synthetic/hepatocellular dysfunction but little portal hypertension.. or vice versa.

Good argument that the relative contributions of each to MELD-Na might be actionable in this context..

2 1 2

Zaven Sargsyan @sargsyanz.bsky.social · 2d

Back to the future

1

Reposted by Zaven Sargsyan

Juan Carlos Q Vélez, MD @juancarlosqvelez.bsky.social · 2d

Bold much-needed perspective by @sarahsanghavi.bsky.social et al about revisiting TIPS in the context of kidney disease, particularly in some cases of #HRS at #Kidney360 journals.lww.com/kidney360/ab...

journals.lww.com

1 2 3

Zaven Sargsyan @sargsyanz.bsky.social · 4d

And their jugular veins are distended to the jaw even when they’re about to die of resultant septic and hypovolemic shock

Reposted by Zaven Sargsyan

Dr. Longissimus @drlongissimus.bsky.social · 4d

Bats get descending cholangitis

3 1 14

Reposted by Zaven Sargsyan

Atheendar Venkataramani @atheendar.bsky.social · 4d

I did a five month experiment where I signed off all social media. I felt smarter + less angry and distracted.

Alex de Campi @alexdecampi.bsky.social · 4d

A thought I keep having: what if I just log off all social media and subscribe to a few paper magazines and newspapers instead

1 1 5

Zaven Sargsyan @sargsyanz.bsky.social · 5d

Congrats on 500, @thecurbsiders.bsky.social !

The episode was good, too. Would recommend it to folks wanting some updates on COPD, which there are many.

Even thymic stromal lymphopoietin made an appearance @paulnwilliams.bsky.social

thecurbsiders.bsky.social @thecurbsiders.bsky.social · 5d

🎉 We’re celebrating our 500th episode with a GIVEAWAY! 🎉

That’s 500 servings of knowledge food for your brain holes 🧠🍽️ — and we couldn’t have done it without YOU! Use the link below for more details! 👇🏼

www.instagram.com/p/DPejD3xEek...

1 1 4

Reposted by Zaven Sargsyan

🧛VÆmpiric @empiricgame.bsky.social · 5d

Packing a lunch is not enough. You also need to bring it to work.

1 6

Zaven Sargsyan @sargsyanz.bsky.social · 5d

I've been thinking recently about how we heavily from ACEi -> ARB over the last 15 years, and that drug-induced chronic cough became much less common.

But now we've gone / we're going ARB -> ARNI for a lot of patients. Back on the bradykinin train. Drug-induced cough probs increasing again.

1